- Hem
- Om universitetet
- Hitta person
- Karl Hansson
Karl Hansson
Forskare
Avd för medicinsk kemi och cellbiologi-
Enteric nervous system-derived VIP restrains differentiation of LGR5+ stem cells toward the secretory lineage impeding type 2 immune
programs
Manuel O. Jakob, Nele Sterczyk, Sotiria Boulekou, Patrycja M. Forster, Luisa Barleben, Nadra Alzain, Katja J. Jarick, Roksana M. Pirzgalska, Bruno Raposo, Karl Hansson, Elisabeth Nyström, Aurelia Gondrand, Miguel Gonzalez-Acera, Pierre S. Leclere, Marlen S. Lapson, Sarah Poggenseier, Divija Deshpande, Laura Velleman, Tilman Breiderhoff, Max Felix Brunkhorst, Anton M. Schule, Gabriela M. Guerra, Pawel Durek, Mir-Farzin Mashreghi, Anja A. Kuhl, Coco Chu, Christoph Schneider, Carl Weidinger, Britta Siegmund, Thierry M. Nordmann, David Voehringer, Jay V. Patankar, Christoph Becker, George Birchenough, Henrique Veiga-Fernandes, Francesca Ronchi, Marina Kolesnichenko, Andreas Diefenbach, Christoph S. N. Klose
NATURE IMMUNOLOGY - 2025 -
Muc2-dependent microbial colonization of the jejunal mucus layer is diet sensitive and confers local resistance to enteric pathogen
infection
George M. H. Birchenough, Björn O. Schröder, Sinan Sharba, Liisa Arike, Christian V Recktenwald, F. Puertolas-Balint, Mahadevan Subramani, Karl Hansson, B. Yilmaz, Sara K. Lindén, Fredrik Bäckhed, Gunnar C. Hansson
Cell Reports - 2023 -
Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019)
74-82].
Karl Hansson, Rahil Dahlén, Oskar Hansson, Elin Pernevik, Ross Paterson, Jonathan M Schott, Nadia Magdalinou, Henrik Zetterberg, Kaj Blennow, Johan Gobom
Journal of mass spectrometry and advances in the clinical lab - 2022 -
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's
disease
Karl Hansson, Rahil Dahlén, O. Hansson, Elin Pernevik, R. Paterson, J. M. Schott, N. Magdalinou, Henrik Zetterberg, Kaj Blennow, Johan Gobom
Clinical Mass Spectrometry - 2019 -
Cerebrospinal fluid peptidomics: discovery of endogenous peptides as biomarkers of Alzheimer's
disease
Karl Hansson
2018 -
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal
Fluid
Karl Hansson, Tobias Skillbäck, Elin Pernevik, Jessica Holmén Larsson, Gunnar Brinkmalm, Kaj Blennow, Henrik Zetterberg, Johan Gobom
Jove-Journal of Visualized Experiments - 2017 -
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's
disease
Tobias Skillbäck, Niklas Mattsson, Karl Hansson, Ekaterina Mirgorodskaya, Rahil Dahlén, W. van der Flier, P. Scheltens, F. Duits, O. Hansson, C. Teunissen, Kaj Blennow, Henrik Zetterberg, Johan Gobom
Scientific Reports - 2017 -
Expanding the cerebrospinal fluid
endopeptidome
Karl Hansson, Tobias Skillbäck, Elin Pernevik, Silke Kern, Erik Portelius, Kina Höglund, Gunnar Brinkmalm, Jessica Holmén Larsson, Kaj Blennow, Henrik Zetterberg, Johan Gobom
Proteomics - 2017 -
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker
Candidates.
Claire L Russell, Vikram Mitra, Karl Hansson, Kaj Blennow, Johan Gobom, Henrik Zetterberg, Mikko Hiltunen, Malcolm Ward, Ian Pike
Journal of Alzheimer's disease : JAD - 2017